Shital Pema, DPM
Primary Podiatric Medicine · Kettering, OHNPI 1780640995
Payments from drug & device makers
What this record shows
This record is dominated by other: $237,254 of the $298,665 with a category attached, or 79.4%. Johnson & Johnson accounts for 79.5% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2022 at $237,642 and has fallen 98.4% since, to $3,903 in 2025.
Across 213 payments — averaging $1402.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$237K
- Bone Support Inc.$15K
- DNE LLC$12K
- Orthofix Medical, Inc.$5K
- CDC Medical LLC$5K
- Stryker$4K
- plus $20K from 26 others
What the payments were for
- Consulting fees$21,8757%
- Speaking & faculty fees$10,0003%
- Travel & lodging$23,0328%
- Food & beverage$4,8652%
- Education$1,6401%
- Other$237,25479%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 7 | $237,312 |
| Bone Support Inc. | 8 | $15,070 |
| DNE LLC | 5 | $11,975 |
| Orthofix Medical, Inc. | 28 | $5,426 |
| CDC Medical LLC | 6 | $4,794 |
| Stryker | 38 | $3,904 |
| Extremity Medical | 4 | $3,401 |
| Ossdsign USA Incorporated | 3 | $2,797 |
| Integra Lifesciences Corporation | 17 | $2,787 |
| Avita Medical Americas, LLC | 22 | $2,503 |
| Medshape, Inc. | 6 | $2,116 |
| Smith+Nephew | 14 | $2,116 |
| Vilex LLC | 7 | $1,886 |
| Paragon 28, Inc. | 3 | $580 |
| Arthrex | 4 | $481 |
| Convatec Inc. | 5 | $300 |
| Curonix LLC | 3 | $261 |
| Kerecis Limited | 3 | $236 |
| Nevro Corp. | 7 | $198 |
| Abbott | 2 | $110 |
| Bioventus LLC | 3 | $68 |
| Trilliant Surgical LLC. | 2 | $51 |
| Sanara Medtech Inc. | 2 | $48 |
| Misonix Inc | 2 | $36 |
| Solventum Corporation | 1 | $32 |
| Baxter Healthcare | 2 | $32 |
| Avinger Inc. | 1 | $30 |
| Lifenet Health | 4 | $29 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| Acera Surgical, Inc. | 1 | $24 |
| Legacy Ortho LLC | 1 | $19 |
| Deroyal Industries, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$14,987
- INTEGRA$6,565
- TrueLok$6,183
- SEAL$4,000
- PRIMATRIX$2,495
- INTEGRA DERMAL REGENERATION TEMPLATE$2,188
- RECELL$1,990
- Taylor Spatial Frame$1,834
- HINTERMANN$1,721
- PROstep$1,381
- Oasis$1,127
- DynaNail Hybrid$1,096
- DynaNail$735
- INBONE$722
- Portfolio$529
- HOFFMANN$510
- MOTOBAND$424
- SURGIMEND$307
- TCC-EZ$307
- NEURAGEN$307
How this compares
Too few primary podiatric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 19 | $6,156 |
| Enoxaparin Sodium | 13 | $835 |
| Celecoxib | 16 | $568 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $291 |
| Ammonium Lactate | 17 | $241 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $214 |
| Cephalexin | 26 | $153 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $93 |
| Doxycycline Hyclate | 12 | $91 |
| Methylprednisolone | 11 | $84 |
| Ibuprofen | 29 | $76 |
| Tramadol Hcl | 17 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $2,116 | $6,15619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few primary podiatric medicine providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other primary podiatric medicine in Kettering
- Brock LidenCircleville$453K
- Megan OltmannSolon$177K
- Gary MostChesterland$4K
- Thomas CiresiRichmond Heights$4K
- Tiffany LiuDublin$3K
- David BaerColumbiana$3K
- Abena AgyepongCincinnati$3K
- Samuel MakanjuolaColumbus$2K
- Matthew NarducciColumbiana$2K
- Joseph ArtersYoungstown$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.